Steven A. Johnson, PhD

Vice-President, Drug Development

Dr. Johnson has more than 20 years experience in pharmaceutical research, preclinical and clinical drug development. Prior to joining Neurolixis, Dr. Johnson held a series of positions managing drug discovery, preclinical and clinical research at Cortex Pharmaceuticals, Inc (Irvine, CA), most recent of which was VP of Preclinical Development and Executive Officer. Prior to Cortex he was an Assistant Professor of Neurogerontology at the University of Southern California (USC; Los Angeles, CA), where he focused on the molecular biology and molecular pathology of Alzheimer’s disease. Prior to joining the research faculty at USC, Dr. Johnson received post-doctoral training at the California Institute of Technology (CalTech; Pasadena, CA) and at USC. Dr. Johnson has served on a number of state (California) and federal (National Institute of Health) funding review panels, has been a reviewer for several aging and neurobiology journals, has published more than 50 articles and book chapters, and holds 1 patent. Dr. Johnson received a B.S. from Oregon State University and a Ph.D. in Biology from Purdue University (W. Lafayette, IN).